This is the logo of the provider
ERA 2026 3 - 6 June 2026

The Effects of Semaglutide on Health-Related Quality of Life in Adults with Type 2 Diabetes and Chronic Kidney Disease: FLOW trial

Authors :

Johannes Mann1,2; Ida Kirstine Bull Rasmussen3; Thomas P Gunnarsson3; Prachi Priyadarshini4;Søren Rasmussen3; Peter Rossing5

Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Keywords
Diabetes
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)